GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vanda Pharmaceuticals Inc. (VNDA) [hlAlert]

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug
discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.
( Total: 11 Current Stock Recommendations )
Vanda Pharmaceuticals Inc.   (11)
Hold 18% Buy 82%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy VNDA
down 8.05 %

Rating:
Buy VNDA
up 213.87 %
Vanda Pharmaceuticals Inc. (VNDA) rated Overweight by Piper Jaffray
Wednesday,  Nov 27, 2013  8:25 AM ET

Rating:
Buy VNDA
up 213.87 %

Rating:
Buy VNDA
up 197.51 %
Vanda Pharmaceuticals Inc. (VNDA) rated Buy by Jefferies
Thursday,  Feb 14, 2013  8:25 AM ET

Rating:
Buy VNDA
up 200.50 %
Vanda Pharmaceuticals Inc. (VNDA) rated Buy by Lazard
Tuesday,  Feb 5, 2013  8:25 AM ET

Rating:
Buy VNDA
up 188.91 %

Rating:
Buy VNDA
up 12.47 %

Rating:
Buy VNDA
up 2.91 %

Rating:
Buy VNDA
up 2.91 %

Rating:
Hold VNDA
Vanda Pharmaceuticals Inc. (VNDA) rated Neutral by JP Morgan
Tuesday,  Jul 29, 2008  8:25 AM ET

Rating:
Hold VNDA
down 93.62 %

Rating:
Buy VNDA
Vanda Pharma (VNDA) rated BUY
Thursday,  Jul 10, 2008  8:25 AM ET

Rating:
Buy VNDA
up 178.83 %

Rating:
Buy VNDA
down 93.62 %
Vanda Pharmaceuticals Inc. (VNDA) rated Buy
Monday,  Sep 10, 2007  9:25 AM ET

Rating:
Buy VNDA
up 5.26 %
Vanda Pharmaceuticals Inc. (VNDA) rated Buy
Thursday,  Nov 1, 2007  3:25 PM ET

Your Recent Stocks
SymbolLastChange
VNDA 8.72 down  -27.27 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy